Carbios Wins Key Lender Approvals for Longlaville as Beverage Deal Holds the Financing Together
Published on 10/03/2026 at 01:10 | Editorial boerse-global.de
Carbios has cleared a decisive hurdle in the long-running effort to get its first large-scale enzymatic recycling plant off the ground. A majority of the syndicate banks backing the Longlaville project have now secured approval from their credit committees, according to the company — a step that moves the French firm closer to the construction phase but stops short of a fully closed financing package.
The remaining pieces are still being assembled. Export credit agencies and equity partners are continuing their due diligence, and a commercial agreement in the beverage sector is in the final stages of negotiation. That contract carries outsized weight: it would lift pre-sales to 60% of the plant's nominal capacity, a threshold the company regards as essential for convincing the outstanding backers of the project's economics.
Textile Recycling Passes Its Factory-Floor Test
While the financing talks grind on behind the scenes, Carbios delivered a separate proof point on the technical side. Working inside the Fiber-to-Fiber consortium alongside Patagonia, PUMA and Salomon, the company produced T-shirts from recycled polyester on European production lines. The feedstock was mixed textile and plastic waste, and the run yielded more than one tonne of EnzyTex, the enzymatically manufactured material.
According to the company, the resulting fibers match the performance of standard petroleum-based polyester. That matters because sportswear and fashion brands are hunting for circular alternatives to synthetic blends that are notoriously difficult to separate. For Carbios, the trial is the clearest sign yet that its bio-based process can hold up under real manufacturing conditions rather than just in the lab.
Should investors sell immediately? Or is it worth buying Carbios?
Half-Year Numbers Show a Tighter Ship
The development phase left its mark on the interim results published roughly a week ago. Carbios trimmed its spending, bringing operating expenses down 19% year on year, and the net loss narrowed to EUR 9.4 million. The operating loss for the period stood at EUR 11.8 million.
Cash is the metric that matters most at this stage of a company's life, before licensing income or its own plants start generating steady revenue. At the end of June, Carbios held EUR 48 million in liquid funds — a cushion that gives management room to maneuver but not unlimited time. Investors are watching closely how efficiently that money is deployed, particularly with heavy upfront spending on the planned plant still ahead.
The Beverage Contract as Linchpin
The strategic logic of the beverage deal extends beyond the order book. If it closes, more than half of future output would be contractually locked in before construction even begins, sharply reducing the sales risk attached to Longlaville. A positive outcome would also unlock the disbursement of the bank loans already approved in principle.
Should the agreement stall or fall apart, the arithmetic changes quickly. Without the 60% pre-sale ratio, the credit committee approvals already granted could lose their validity. In that scenario, the company might have little choice but to tap equity markets — a route that would dilute existing shareholders meaningfully.
Two Milestones to Watch
For investors, the coming months boil down to a pair of concrete signals: the final signing of the beverage supply contract and the binding release of the full Longlaville financing package. As long as the banking approvals hold and the export credit agency reviews move forward, the groundwork for construction remains intact. If a key partner withdraws its commitment or due diligence drags on, pressure on the EUR 48 million cash position will mount fast.
The equity has been under sustained pressure. At EUR 5.47, the stock has lost 52% since the start of the year, leaving a market capitalization of EUR 100.22 million. That decline reflects the market's core question: how quickly can Carbios convert its enzymatic platform from a validated technology into a commercially viable industrial operation? The answer, for now, rests on whether the financing pieces fall into place before the cash pile runs thin.
Ad
Carbios Stock: New Analysis - 3 October
Fresh Carbios information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
